These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23242192)

  • 21. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
    Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
    Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations.
    Varma N; Michalski J; Stambler B; Pavri BB;
    Eur Heart J; 2014 May; 35(20):1345-52. PubMed ID: 24595864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication?
    Hofer D; Steffel J; Hürlimann D; Haegeli L; Lüscher TF; Duru F; Eriksson U; Krasniqi N
    J Interv Card Electrophysiol; 2017 Dec; 50(3):219-226. PubMed ID: 29177981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact).
    Hansen C; Loges C; Seidl K; Eberhardt F; Tröster H; Petrov K; Grönefeld G; Bramlage P; Birkenhauer F; Weiss C
    BMC Cardiovasc Disord; 2018 Jun; 18(1):131. PubMed ID: 29954340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Home monitoring" for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study.
    Hauck M; Bauer A; Voss F; Weretka S; Katus HA; Becker R
    Clin Res Cardiol; 2009 Jan; 98(1):19-24. PubMed ID: 18776998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
    Lazarus A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S2-S12. PubMed ID: 17302706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.
    Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R
    Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ICD function and dysfunction in patients with arrhythmogenic cardiac diseases: the role of home monitoring.
    De Asmundis C; Ricciardi D; Namdar M; Pappaert G; Rodríguez-Mañero M; Wauters K; Casado-Arroyo R; Rao JJ; Bayrak F; Chierchia GB; Sarkozy A; Brugada P
    Acta Cardiol; 2013 Aug; 68(4):387-94. PubMed ID: 24187765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual clinics for follow-up of pacemakers and implantable cardioverter defibrillators in children.
    Spentzou G; Mayne K; Fulton H; McLeod K
    Cardiol Young; 2019 Oct; 29(10):1243-1247. PubMed ID: 32167039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
    Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
    Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
    Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
    Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study.
    Sapp JA; Gillis AM; AbdelWahab A; Nault I; Nery PB; Healey JS; Raj SR; Lockwood E; Sterns LD; Sears SF; Wells GA; Yee R; Philippon F; Tang A; Parkash R
    CMAJ Open; 2021; 9(1):E53-E61. PubMed ID: 33495385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience.
    Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.